-
Publication Venue For
-
Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials..
17:e1003117.
2020
-
Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines..
17:e1003038.
2020
-
Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: A targeted metabolomic and transcriptomic study..
17:e1003012.
2020
-
Current situation and progress toward the 2030 health-related Sustainable Development Goals in China: A systematic analysis..
16:e1002975.
2019
-
Early malaria infection, dysregulation of angiogenesis, metabolism and inflammation across pregnancy, and risk of preterm birth in Malawi: A cohort study..
16:e1002914.
2019
-
Portrayals of mental illness, treatment, and relapse and their effects on the stigma of mental illness: Population-based, randomized survey experiment in rural Uganda..
16:e1002908.
2019
-
Community-, facility-, and individual-level outcomes of a district mental healthcare plan in a low-resource setting in Nepal: A population-based evaluation..
16:e1002748.
2019
-
Deep learning for chest radiograph diagnosis: A retrospective comparison of the CheXNeXt algorithm to practicing radiologists..
15:e1002686.
2018
-
Development and validation of machine learning models to identify high-risk surgical patients using automatically curated electronic health record data (Pythia): A retrospective, single-site study..
15:e1002701.
2018
-
Correction: Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis..
15:e1002637.
2018
-
Improving rational use of ACTs through diagnosis-dependent subsidies: Evidence from a cluster-randomized controlled trial in western Kenya..
15:e1002607.
2018
-
Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis..
15:e1002572.
2018
-
Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study..
15:e1002482.
2018
-
Research on HIV cure: Mapping the ethics landscape..
14:e1002470.
2017
-
Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial..
14:e1002435.
2017
-
malERA: An updated research agenda for characterising the reservoir and measuring transmission in malaria elimination and eradication..
14:e1002452.
2017
-
Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis..
14:e1002383.
2017
-
Self-monitoring of blood pressure in hypertension: A systematic review and individual patient data meta-analysis..
14:e1002389.
2017
-
Fresh fruit consumption in relation to incident diabetes and diabetic vascular complications: A 7-y prospective study of 0.5 million Chinese adults..
14:e1002279.
2017
-
Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine..
13:e1002136.
2016
-
The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study..
13:e1002181.
2016
-
Association between Adult Height and Risk of Colorectal, Lung, and Prostate Cancer: Results from Meta-analyses of Prospective Studies and Mendelian Randomization Analyses..
13:e1002118.
2016
-
Scheduled Intermittent Screening with Rapid Diagnostic Tests and Treatment with Dihydroartemisinin-Piperaquine versus Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy in Malawi: An Open-Label Randomized Controlled Trial..
13:e1002124.
2016
-
Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola..
13:e1002042.
2016
-
Associations between Potentially Modifiable Risk Factors and Alzheimer Disease: A Mendelian Randomization Study..
12:e1001841.
2015
-
The kSORT assay to detect renal transplant patients at high risk for acute rejection: results of the multicenter AART study..
11:e1001759.
2014
-
HIV monoclonal antibodies: a new opportunity to further reduce mother-to-child HIV transmission..
11:e1001616.
2014
-
Impact of intermittent screening and treatment for malaria among school children in Kenya: a cluster randomised trial..
11:e1001594.
2014
-
Managing incidental genomic findings in clinical trials: fulfillment of the principle of justice..
11:e1001584.
2014
-
Reproductive and maternal health in the post-2015 era: cervical cancer must be a priority..
10:e1001499.
2013
-
Research misconduct in low- and middle-income countries..
10:e1001315.
2013
-
Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settings..
9:e1001290.
2012
-
Informing the 2011 UN Session on Noncommunicable Diseases: applying lessons from the AIDS response..
8:e1001086.
2011
-
Air Pollution and the microvasculature: a cross-sectional assessment of in vivo retinal images in the population-based multi-ethnic study of atherosclerosis (MESA)..
7:e1000372.
2010
-
Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infection..
6:e1000107.
2009
-
Will the public's health fall victim to the home foreclosure epidemic?.
6:e1000087.
2009
-
Evaluation and recommendations on good clinical laboratory practice guidelines for phase I-III clinical trials..
6:e1000067.
2009
-
Evaluation and Recommendations on Good Clinical Laboratory Practice Guidelines for Phase I-III Clinical Trials.
6.
2009
-
Unrecognized non-Q-wave myocardial infarction: prevalence and prognostic significance in patients with suspected coronary disease..
6:e1000057.
2009
-
STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement..
6:e22.
2009
-
African AIDS vaccine programme for a coordinated and collaborative vaccine development effort on the continent..
5:e236.
2008
-
The infectiousness of tuberculosis patients coinfected with HIV..
5:e188.
2008
-
The use of nonhuman primate models in HIV vaccine development..
5:e173.
2008
-
False hopes, unwarranted fears: the trouble with medical news stories..
5:e118.
2008
-
Improving defences at the portal of HIV entry: mucosal and innate immunity..
5:e81.
2008
-
Antibody-based HIV-1 vaccines: recent developments and future directions..
4:e348.
2007
-
Clinical trials and medical care: defining the therapeutic misconception..
4:e324.
2007
-
How can we draw the line between clinical care and medical research..
4:e340.
2007
-
Which single intervention would do the most to improve the health of those living on less than $1 per day? Interview by Gavin Yamey..
4:1557-1560.
2007
-
Defining human differences in biomedicine..
4:e288.
2007
-
Beta-catenin signaling plays a disparate role in different phases of fracture repair: implications for therapy to improve bone healing..
4:e249.
2007
-
Gene expression signatures that predict radiation exposure in mice and humans..
4:e106.
2007
-
Management of cryptococcosis: how are we doing?.
4:e47.
2007
-
Natural ventilation for the prevention of airborne contagion..
4:e68.
2007
-
Metabolic profiling of patients with schizophrenia..
3:e363.
2006
-
Insensitivity of paediatric HIV-1 subtype C viruses to broadly neutralising monoclonal antibodies raised against subtype B..
3:e255.
2006
-
Hyperinfectivity in cholera: a new mechanism for an old epidemiological model?.
3:e280.
2006
-
Potential impact of intermittent preventive treatment (IPT) on spread of drug-resistant malaria..
3:e141.
2006
-
Clinical trials registration..
3:e157.
2006
-
Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers..
3:e47.
2006
-
An alternative and effective HIV vaccination approach based on inhibition of antigen presentation attenuators in dendritic cells..
3:e11.
2006
-
Metabolic profiling of patients with schizophrenia..
3.
2006
-
Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants..
2:e313.
2005
-
Inhibition of endothelial activation: a new way to treat cerebral malaria?.
2:e245.
2005
-
Unjustified restrictions on letters to the editor..
2:e126-e152.
2005
-
Exercise and health: can biotechnology confer similar benefits?.
2:e68.
2005
-
Should an institution that has commercial rights in a new drug or device be allowed to evaluate the technology?.
2:e9.
2005